Karrer S
Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Deutschland.
Hautarzt. 2011 Jul;62(7):493-503. doi: 10.1007/s00105-010-2112-7.
Diabetic foot syndrome is a major complication for patients with diabetes mellitus. About 25% of the 6 million patients with diabetes in Germany will suffer from diabetic foot syndrome at some point during the course of disease. Diabetic neuropathy and peripheral vascular disease are the main causative factors in the pathogenesis of diabetic foot ulcers. The mortality rate of these patients is more than twice as high as that of the average population. 25% of costs incurred by patients with diabetes are spent on diabetic foot ulcers, and 50% of hospital days are attributed to the treatment of the diabetic foot syndrome. This syndrome is also the most common cause of non-traumatic amputations. Both the risk of amputation and mortality are much increased in case of peripheral vascular disease. Hence, the aim is to lower the still high number of amputations in Germany by appropriate preventive measures as well as by multidisciplinary diagnostics and therapy.
糖尿病足综合征是糖尿病患者的一种主要并发症。在德国600万糖尿病患者中,约25%在病程中的某个阶段会患上糖尿病足综合征。糖尿病神经病变和外周血管疾病是糖尿病足溃疡发病机制中的主要致病因素。这些患者的死亡率比普通人群高出两倍多。糖尿病患者所产生费用的25%用于糖尿病足溃疡,50%的住院天数归因于糖尿病足综合征的治疗。该综合征也是非创伤性截肢最常见的原因。在外周血管疾病的情况下,截肢风险和死亡率都会大幅增加。因此,目标是通过适当的预防措施以及多学科诊断和治疗,降低德国仍然居高不下的截肢数量。